New Delhi, Oct. 6 -- Within days of announcing its MHRA registration for its AI-powered Renalyx haemodialysis system, Lord's Mark Industries Limited has secured another regulatory milestone in the UK & UK allied markets, with its IVD portfolio registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA), strengthening the company's plans to establish a broader healthcare and diagnostics presence across the UK and UK-allied markets .

The latest registration, dated September 24, 2026, records Lord's Mark Industries as a registered manufacturer and covers IVD categories including haematological cell analysers, multiple clinical chemistry analysers, buffered sample diluents and instrument/analyser cleaning agents.

The...